

[1] โ September 28, 2013 โThe Skepticsโขโ Burzynski discussion: By Bob Blaskiewicz โ 2:19:51
======================================
BB โ Bob Blaskiewicz
โโโโโโโโโโโโโโโโโโโโโโ
DJT โ Didymus Judas Thomas
======================================
0:47:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Ummm, o-kay”
“Uh, I want to turn this over to the people who are watching”
“Um, I want to give them a a chance to address you as well”
“Uhmmm, hi everyone”
โโโโโโโโโโโโโโโโโโโโโโ
0:48:00
โโโโโโโโโโโโโโโโโโโโโโ
0:53:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “A every time that I and and and and, and David (James @StortSkeptic the Skeptic Canary) points this out, that um, you you know you’re not going to speculate about the the FDA but then at every turn you’re invoking the FDA as being obstructionist“
โโโโโโโโโโโโโโโโโโโโโโ
0:54:02
โโโโโโโโโโโโโโโโโโโโโโ
BB – “I, I just find that to be contradictory and and self-defeating“
======================================
DJT โ Bob, exactly where did I invoke “the FDA as being obstructionist” ?
======================================
1:02:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Um, itโs itโs itโs not the FDAโs, but you understand itโs not the FDAโs job to tell someone that their drug doesnโt work“
โโโโโโโโโโโโโโโโโโโโโโ
1:03:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “itโs itโs itโs up to Burzynski“
“Itโs up to Burzynski to show that his drug does work”
“And itโs always been his burden of proof“
“Heโs the one thatโs been claiming this miracle cancer cure, forever”
======================================
DJT โ Bob, Burzynski showed and proved what he needed to prove to the FDA in order to do phase 2 clinical trials, 9/3/2004 โ FDA granted โorphan drug designationโ (โODDโ) for Antineoplastons (A10 & AS2-1 Antineoplaston) for treatment of patients with brain stem glioma, .10/30/2008 โ FDA granted โorphan drug designationโ (โODDโ) for Antineoplastons (A10 and AS2-1 Antineoplaston) for treatment of gliomas, and FDA approved phase 3 [1-2]
Oh, and Bob, exactly when did Burzynski 1st claim “this miracle cancer cure” ?
======================================
1:04:02
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Um, that weโd love to see, however we canโt see, however we canโt see it because of proti protri proprietary uh protections that the FDA is giving to Burzynski, right ?”
“Theyโre not sharing his trial designs because they are his trial designs, right ?”
“That the makeup of his drug that heโs distributing are his, uh design, and his intellectual property“
“So the FDA is protecting him, uh from outside scrutiny“
======================================
DJT โ Bob, you make it sound like it’s part of some grand “conspiracy” between Burzynski and the FDA to keep information from โThe Skepticsโขโ [3]
โโโโโโโโโโโโโโโโโโโโโโ
21CFR601
Subpart FโConfidentiality of Information
Sec. 601.50
Confidentiality of data and information in an investigational new drug notice for a biological product
(a) The existence of an IND notice for a biological product will not be disclosed by the Food and Drug Administration unless it has previously been publicly disclosed or acknowledged
======================================
BB – “While you may imagine that that, that that the FDA is is somehow antagonistic toward him“
“Theyโve given him every opportunity, over 60 opportunities to prove himself worth uh their confidence and hasnโt“
======================================
DJT โ Bob, that certainly explains the 9/3/2004 and .10/30/2008 ODD’s and phase 3 clinical trial approvals by the FDA – NOT [1-2]
======================================
1:05:00
โโโโโโโโโโโโโโโโโโโโโโ
1:42:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “I donโt, the thing is though that, that thatโs a inver, shifting the burden of proof off of Burzynski”
“Burzynski has to prove them wrong, has to prove him right”
“The FDA is not there to say this doesnโt work”
======================================
DJT โ Bob, who initiated and put into place the clinical trial hold ?
Burzynski ?
FDA ?
Both ?
======================================
1:43:30
โโโโโโโโโโโโโโโโโโโโโโ
BB – “So, I mean, honestly, um, saying โWell, when the F, FDA tells you that it doesnโt work, the FDAโs never gonna say that because thatโs not their job“
โโโโโโโโโโโโโโโโโโโโโโ
1:44:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Thatโs not an option, because theyโre never gonna do it“
“They relinquish, a lot of authority, over to Burzynski, and his Institutional Review Board, which, I would mention, has failed 3 reviews in a row”
======================================
Bob, where are the “final reports” for those “3 reviews” ?
======================================
BB – “Right ?”
“It is Burzynskiโs job to be convincing”
“It is not our uh, uh, it it it he hasnโt produced in decades“
“In decades”
“In hundreds and hundreds of patients, whoโve payed to be on this”
“Hell, weโd weโd weโd like a prelim, well when youโre talking about something that is so difficult as brainstem glioma, that type of thing gets, really does in the publishing stream get fast-tracked there”
======================================
DJT โ Bob, Burzynski has provided numerous phase 2 clinical trial preliminary reports, which our #fave oncologist has chosen to ignore [4]
======================================
BB – “they test it”
“Yeah, and they they they want uh, that was evidence of fast-tracking is what, that rejection was uh e was very quickly“
======================================
DJT โ Bob, have you checked The Lancet Oncology [5] to see what was so much more important than Burzynski’s “phase 2 clinical trial Progression-Free Survival (PFS) and Overall Survival (OS) re patients 8 โ 16 years after diagnosis, results” [6] and the Japanese antineoplaston study ? [7]
======================================
BB – “So, how long will it be before Burzynski doesnโt publish, that you decide that uh perhaps heโs he‘s, doesnโt have the goods ?“
“Um, so, uh, uh again, the FDA is not the arbiter of this“
“Itโs ultimately Burzynski”
“Youโve been speculating about what the FDAโs motivation are like crazy”
“Why not speculate about Burzynski a little bit”
======================================
DJT – Well, how have I been speculating ?
======================================
1:46:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Well actually Iโm not even asking you to speculate about Burzynski, Iโm only asking you to tell me, how long would it take, uh how, for him to go unpublished like this, um, for this long, before you would doubt it ?”
======================================
DJT โ Note how, above, without proving it, Bob claimed “at every turn you’re invoking the FDA as being obstructionist”, and now, directly above, again, without proving it, Bob claims “Youโve been speculating about what the FDAโs motivation are like crazy”
โโโโโโโโโโโโโโโโโโโโโโ
DJT – what the journals keep saying, in response
======================================
BB – “What ?”
======================================
DJT – You know, are they going to give The Lancet response, like they did in 2 hours and such, saying, โWell, we think your message would be best heard elsewhere,โ or they gonna gonna give The Lancet response of, โWell, we donโt have room in our publication this time, well, because weโre full up, so, try and pick another place” ?
======================================
BB – “But these but but but that doesnโt have any bearing on“
“That doesnโt”
“Oh Iโm not asking you how long, how long, would it take you for you to start doubting whether or not he has the goods ?“
“How long would it take ?”
“Itโs a itโs a itโs a question that should be answered by a number uh uh months ?“
“Years ?”
“How long ?”
“Itโs been 15 years already”
======================================
DJT – Well, you like to jump up and down with the “15 year” quote, but then again I always get back to, Hey, itโs when, when the report, when the clinical trial is done
โโโโโโโโโโโโโโโโโโโโโโ
1:47:06
โโโโโโโโโโโโโโโโโโโโโโ
DJT – Not that heโs been practicing medicine medicine for 36 years, or whatever, itโs when the clin, clinical trial was done
======================================
BB – “I could push it back to 36 years”
“He hasnโt shown that it works for 36 years”
“I can do that”
“I was being nice”
======================================
DJT โ Note how Bob acts like he’s been hit with “The Stupid Stick”
If he wants to go back “36 years”, I can refer back to 1991 (11/15/1991) โ Michael J. Hawkins, M.D., Chief, Investigational Drug Branch, Department of Health &Human Services (HHS), Public Health Service, National Institutes of Health (NIH), National Cancer Institute (NCI), sent a 1 page Memorandum Re:
Antineoplaston to Decision Network, which advised, in part:
โIt was the opinion of the site visit team that antitumor activity was documented in this best case series and that the conduct of Phase II trials was indicated to determine the response rateโ [8]
โโโโโโโโโโโโโโโโโโโโโโ
DJT – The FDA A believes there is evidence of efficacy
======================================
BB – “Perhaps based on bad phase 2”
======================================
DJT – Well, we donโt know that
We donโt have the Freedom of Information Act information
โโโโโโโโโโโโโโโโโโโโโโ
DJT โ Remember, Bob is the one who told me during the 9/28/2013 Google+ Burzynski Discussion Hangout:
“Youโre youโre youโre assuming”
“Youโre youโre youโre assuming that”
“Youโre assuming that”
“Um, Iโm not assuming that”
“There is a correct answer here”
“You donโt know”
“You donโt know”
“You need to look into it”
“Alright ?”
“Before you dismiss it you have to look into it”
“Everytime somebody throws uh uh something to me,
I have to look into it”
“Thatโs just, itโs my responsibility as a reader”
“T t and what I would honestly expect and hope, is that you would be honest about this, to yourself, and and and thatโs the thing we donโt, we often donโt realize that weโre not being honest with ourself“
“I try to fight against it, constantly”
Bob just ASSUMED that the FDA approved phase 3 clinical trials for Burzynski “Perhaps based on bad phase 2”, but tells me NOT to ASSUME ?
======================================
BB – “He withdrew”
“He withdrew the the phase 3 clinical trial”
“I that before recruiting,
although Iโve seen lots of people say they were on a phase 3 clinical trial“
“I wonder how that happened”
======================================
DJT – Well, we know what happened in the movie because Eric particularly covered that when they tried to get what, what, was it 200 or 300 something institutions to take on a phase 3, and they refused
======================================
1:48:01
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Uh did do do you think that if they thought that he was a real doctor that they all would have refused like that ?“
======================================
DJT – Well, Eric gave the reasons that they said they would not take a particular uh phase 3
And so using that excuse that you you just gave there, Iโm not even gonna buy that one, because thatโs not one of the reasons
โโโโโโโโโโโโโโโโโโโโโโ
Note how Bob pulls out the old “if they thought that he was a real doctor” line ?
Is Bob now claiming that Burzynski is NOT even a “real doctor” ?
======================================
BB – “Heโs changed things”
======================================
DJT – Eric said they gave
======================================
BB – “That The Lancet is a top-tier journal like New England Journal of Medicine“
“Itโs basically be, besieged by uh 100โฒs of people submitting their, their, their reports”
“Um, itโs just, you know, letโs say he, someone has such a thin publishing record as Burzynski does, do you think that itโs likely that he will ever get in a top-tier journal ?“
“What about the the Public Library of Science?”
“Itโs not the only journal there”
“What about BMC Cancer ?”
“Thereโs lots of places that he can go”
======================================
DJT – Weโll Iโm
======================================
BB – “Um, and he doesnโt seem to to have evailed himself of that, as far as I can tell“
“And I would know because heโd get rejected, or heโd be crowing, you know”
โโโโโโโโโโโโโโโโโโโโโโ
1:49:02
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Either way, heโs gonna tell us what happens”
“He told us what happened with The Lancet, you know”
“I donโt have any evidence that suggests to me that heโs even trying”
======================================
Note how Bob refers to Burzynski’s numerous publications as “such a thin publishing record”
Bob, do I need to count all of these for you ? [9]
โโโโโโโโโโโโโโโโโโโโโโ
DJT – Well, Iโm, Iโm sure that theyโre going to keep you appraised just like they have in the past, just like Eric has done in the past
So
I mean, weโll see what happens with the Japanese study [7]
======================================
BB – “So letโs go back to this”
“How long will it take ?”
“How long will it take before you, the Japanese studyโs interesting too because we should be able to find that in the Japanese science databases, and we can find, we canโt find it at all“
“We canโt find it anywhere”
“And, and those are in English, so itโs not a language problem“
“We canโt find that anywhere”
“Weโve asked”
“We asked Rick Schiff, for, for that study”
“And, and it hasnโt come to us“
“He is now I believe on the Board of Directors, over there”
โโโโโโโโโโโโโโโโโโโโโโ
1:50:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “He should have access to this”
“We canโt get it”
======================================
Bob, did you ask:
1. Annals of Oncology 2010;21:viii221 ?
2. European Society for Medical Oncology (ESMO), Colorectal cancer, Abstract: 3558, May 17, 2010 ?
3. Colorectal Cancer Association of Canada, COLORECTAL CANCER RESEARCH, Month Ending June 19, 2009
11. Antineoplaston Therapy Doubles 5-Year Survival Rate Following Curative Resection of Hepatic Mets (May 27/09) pg. 5 of 20 ?
4. Kurume University School of Medicine (Japan) Department of Surgery ?
5. Hideaki Tsuda ? [7]
======================================
BB – “How how long will it take before you recognize that, nothing is forthcoming ?”
“How long would that take ?”
======================================
DJT – Well thatโs like me asking โHow long is it going to take for yโallโs, yโall‘s Skeptics to respond to my questions ?โ
Because yโall havenโt been forthcoming
======================================
BB – “Well, I mean, were talking about a blog here“
“Weโre talking about life”
“No, weโre talking about a bloggerโs feelings in that case“
“In in this case weโre talking about, 1,000โฒs of patients, over the course of of of generations, you know”
“This is important stuff”
“This is not eh eh equating whatโs happening to to patients with whatโs happening to you is is completely off-kilter as far as I can tell“
“Itโs nothing”
“Itโs nothing like you not getting to say something on my web-site”
“You know”
“This is they they have thrown in with Burzynski, and theyโve trusted him, and heโs produced nothing“
“Nothing of substance”
โโโโโโโโโโโโโโโโโโโโโโ
1:51:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Nothing that that has made all of that um, uh, n nothing th th th that uh his peers would take seriously”
“The other thing that that that strikes me now is that, you know, you you you you keep saying that, well Eric is going to to share things with you”
“Does it ever concern you eh uh eh occur to you that Eric might not be reliable ?”
======================================
Bob, do you want to have a contest to determine which of you is more “reliable” ?
======================================
DJT – Well, he gave you The Lancet information and he posted the e-mail in the movie, and Josephine Jones posted a copy of it [6]
======================================
BB – “He then, and then he”
“And then he he, you know, the the the the dialogue that sprung up around that was, well see, heโs never going to get to get published”
“Well youโre just setting yourself up for wish fulfillment”
“You want him to be, persecuted, so you are ecstatic when he doesnโt get to publish, which is unfortunate for all the cancer patients, who really thought that one day, all the studies were going to be published”
โโโโโโโโโโโโโโโโโโโโโโ
1:52:00
======================================
DJT – Well, yโall are free to, you know, claim that all you want, because I donโt always agree with Eric, and uh, heโs free to express his opinion
======================================
BB – “Where has Eric been wrong ?”
======================================
DJT – Well I donโt necessarily believe, what Eric would say about, you know, The Lancet that refused to publish the 2nd one, for the reasons he stated, and which yโall have commented on, including Gorski
You know, I donโt necessarily agree with that
I am more agreeable to yโall, saying that, you know, theyโre busy, theyโve got other things to do, but Iโm kind of still laughing at their 1st response which he showed in the movie about how they felt about, you know his results would be better in some other publication
I thought that was kind of a ridiculous response to give someone
======================================
BB – “Itโs itโs itโs itโs a form letter“
“You know”
“Theyโre just saying, โNo thanksโ”
“โThanks, but no thanksโ is what they were saying, in the most generic way possible”
“Like I said, theyโre besieged by researchers trying to publish“
โโโโโโโโโโโโโโโโโโโโโโ
1:53:05
======================================
DJT – Well you would think that if its a form letter they would use the same form that they used the 2nd time
You know, they didnโt use the same wording that they used the 1st time
I would have think that, you know, their 2nd comment
======================================
BB – “So, so, possibly”
“So possibly what you are saying is that they in fact have read it, and after having read it theyโve rejected it”
“Is that what youโre saying ?”
“Because thatโs what peer-review is”
======================================
DJT – Nah, Iโm not saying that they did that all
Iโm just sayinโ, you know, that they gave, 2 different responses, and I would think that the 2nd one they gave
======================================
BB – “Do you know it was the same editor, that it came from the same desk ?”
“You canโt make that assumption that that the form letter will be the same form letter every time”
“I mean you just canโt“
“I mean in in some ways we have a lot of non-information that youโre filling in, with what you expect, as as opposed to whatโs actually really there, and I I I just think youโre putting too much uh stock in one uh, uh, in in in in this uh the publication kerfuffle“
โโโโโโโโโโโโโโโโโโโโโโ
1:54:16
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Um”
======================================
DJT – Well I find it funny, something along the lines of, you know, โWe believe your message would be received better elsewhere, you know
I donโt see that as a normal response, a scientific publication would send to someone trying to publish something
I mean, to me that sounds, like, if youโre doing that, and youโre The Lancet Oncology, maybe you need to set some different procedures in place, โcuz you would think that with such a great scientific peer-reviewed magazine, that they would have structured things in as far as how they do their operations
======================================
BB – “Well, not necessarily“
“Iโve been in any # of professional groups where the organization is just not optimal, and publications certainly th there are all sorts of pressures from all sorts of different places”
โโโโโโโโโโโโโโโโโโโโโโ
1:55:08
โโโโโโโโโโโโโโโโโโโโโโ
BB – “I I have no problems whatsoever with seeing that this might not be completely uh um uh streamlining uniform processes as possible“
“The fact that itโs not uniform, doesnโt have anything to do with Burzynski not publishing, not producing good data”
“Not just going to a, you know, god, even if, even if, letโs put it this way, even if he went to a pay to play type publication where you have to pay in order to get your manuscript accepted; and he has the money to do this, it wouldnโt take that much, and he were to put out a good protocol, and he were to show us his data, and he would make his, his his stuff accessible to us, then we could validate it, then we could look at it and say, โYeah, this is good,โ or โNo, this is the problem, you have to go back and you have to fix thisโ”
“Right ?”
“So we really, every time we talk about the letter that he got, yeah that doesnโt have much to do with anything, really”
โโโโโโโโโโโโโโโโโโโโโโ
1:56:02
โโโโโโโโโโโโโโโโโโโโโโ
BB – “We wanna see the frickinโ data”
“And if he had a cure for some cancers that otherwise donโt have reliable treatments, he has an obligation to get that out there anyway he can“
“And if if peer-review doesnโt, you know, play a, if peer-review canโt do it, you know, isnโt fast enough for him, then he should take it to the web, and he should send copies out to every pediatric, uh, you know, oncologist that there is“
“Thatโs the way to do it”
======================================
DJT – Well, Iโm sure, Iโm sure Gorski would have a comment about that, as heโs commented previously about how he thinks uh Burzynskishould publish
======================================
1:57:10
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Itโs the, itโs the data itself“
“If if Burzynski is is, is confident in his data, he will put it out there“
“Right ?”
“One way or the other”
======================================
DJT – Like I said before
Like I said before on my blog, you know, even if Burzynski publishes his phase 2 information, Gorski can just jump up and down and say, โWell, that just shows evidence of efficacy, you know, itโs not phase 3,
so it doesnโt really prove itโ
โโโโโโโโโโโโโโโโโโโโโโ
1:58:04
โโโโโโโโโโโโโโโโโโโโโโ
DJT – So then he can go on, you know, for however many years he wants to
======================================
2:01:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Um, almost no treatment goes out without trials“
“Massive amounts of data are required”
======================================
Bob, do you think that’s the 2.5 million pages of clinical trial data that Fabio said Burzynski sent to the FDA ? [10]
======================================
2:02:00
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Uh, in in in that sense, you know, uh all the the the, you know, kind of back-peddling and and and trying to defend him is is going to, not going to help his case at all“
======================================
Bob, exactly where did I exhibit any “kind of back-peddling” ?
======================================
2:03:03
โโโโโโโโโโโโโโโโโโโโโโ
BB – “You are, honestly as far as I can tell you are doing the um, you know, youโre youโre ah throwing up uh, uh, uh, youโre giving me another uh invisible dragon in the garage, um”
======================================
DJT – Well yโall, yโall can call things what yโall want
I mean, yโall can give these, fallacy arguments and all that garbage that yโall like, because thatโs what yโall like to talk about instead of dealing with the issues
I mean, Gorski doesnโt want to deal with the issues
======================================
2:04:11
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Okay, so”
“What youโre telling me is that you trust the FDA to to be able to tell you when heโs not doing, good science, but also that you donโt trust the FDA”
“Do you see an inherent conflict there ?”
======================================
DJT – How did I say I, I didnโt trust them ?
======================================
BB – “Well, when I, whenever I would ask about, like, why would these trials arenโt happening uh and, you know, you say well the the FDAโs arranged it“
“The FDAโs in control”
“They sign off on these things”
“But theyโre theyโre theyโre theyโre at the same that theyโre, theyโre trustworthy theyโre also not trustworthy depending on what you need for the particular argument at the time“
โโโโโโโโโโโโโโโโโโโโโโ
2:05:12
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Youโre suggesting that theyโre untrustworthy”
======================================
DJT – No, Iโm just sayinโ that Iโve raised questions and none of The Skeptics wanna to uh talk about โem [11]
======================================
BB – “Do you know that the FDA pulled out of the prosecution ?”
“Did you know that the FDA pulled out of the prosecution um of his criminal case, because they were backing a researcher ?”
======================================
Bob, would that “researcher” be Dvorit D. Samid, who was in Burzynski: Cancer is Serious Business (Part I) ?
โโโโโโโโโโโโโโโโโโโโโโ
DJT – Well, we know a lot stuff they did, but that still doesnโt impress me that they pulled out of the prosecution
I mean
======================================
BB – “Yeah, the the the it wasnโt the FDA who was pressing charges, it was a Federal prosecutor“
======================================
DJT – Right
======================================
BB – “Right”
“And and, they declined to provide information that the prosecution needed“
“Thatโs important”
“That that thatโs really important“
“That he has been given the benefit of the doubt, and he has come up wanting, for decades now”
======================================
DJT – Well I find it interesting a lot of this uh, a lot of these letters that were provided between, you know, the government and Burzynski, when the uh phase 2 study was going on, at the behest of the NCI
You know, anybody who reads that stuff knows, that when you just ignore the person thatโs been doing, do treating their patients for 20 something years, or close to 20 years, and you change the protocol without his approval, and you donโt use the drugs in the manner that he knows works
======================================
2:10:15
โโโโโโโโโโโโโโโโโโโโโโ
BB – “One of the interesting things about Doubting Thomas that I think you should definitely consider for yourself, is that at some point, when faced with the real opportunity to prove or disprove his assertions, he doubted himself”
“And thatโs important”
“And thatโs where youโre falling short in the analogy”
======================================
DJT – Well, I think The Skeptics, Skeptics are falling short because, you know, they donโt own up to
======================================
BB – “Iโve laid out exactly what it would take for me to turn on a fucking dime”
“I have, I have made it abundantly clear what I need“
“Gorski has made it abundantly clear”
“Everybody else, Guy, and David, and Josephine Jones, uh, the Morgans, all of them have made it abundantly clear, what it would take to change our minds, and youโve never done that”
โโโโโโโโโโโโโโโโโโโโโโ
2:11:02
โโโโโโโโโโโโโโโโโโโโโโ
BB – “And even in this, this was an opportunity to do that“
“To come up with a basis for understanding, where itโs like, you know what, If we can show this, you know, if we can show a this guy, that, that, there, that his standards are not being met, then, you know, we could possibly have some sort of ongoing dialogue after this”
======================================
DJT – So I can say that since the Mayo Clinic (Correction: M.D. Anderson) finished their study in 2006, and it took them until 2013, to actually publish it, then I can say, well, Burzynski finished his in 2009, which was 3 years later, which would give Burzynski until 2016
======================================
BB – “Why wasnโt that study”
======================================
DJT – for me to make up my mind (laughing)
======================================
BB – “Why wasnโt that, that that that, still . . again, it it doesnโt seem really to to approach the the the, main question here“
“You know, um . . what are the standards that you have that it isnโt, what are your standards to show that it isnโt efficacious ?“
โโโโโโโโโโโโโโโโโโโโโโ
2:12:05
======================================
DJT – Well I can say, well Iโm going to have to wait, the same amount of time I had to wait for Mayo (Correction: M.D. Anderson) to publish their study; which was from 2006 to 2013
======================================
BB – “Why was the Mayo”
“Why was the Mayo (Correction: M.D. Anderson) study delayed ?”
======================================
Note how Bob ASSUMES that the publishing of the final results of the M.D. Anderson study were delayed
โโโโโโโโโโโโโโโโโโโโโโ
DJT – How do you know it was delayed ?
======================================
BB – “Well you said you had so many years before you finish it and go in”
======================================
DJT – I mean, has anybody
======================================
BB – “Why, why did it take so long ?“
======================================
DJT – done a review of when a clinical trial is studied, and completed, and how long it took the people to publish it ?
You know
If they could point to me a study thatโs done that, and say, well hereโs the high end, hereโs the low end of the spectrum, hereโs the middle
======================================
BB – “I have something for you, okay ?”
“Send me that”
“Could you send me that study the way that it was published because um, just just send me the final study, um, to my e-mail address”
======================================
DJT – Sure
======================================
BB – “Um, because, I can ask that question of those researchers, why was this study in this time, and what happened in-between”
โโโโโโโโโโโโโโโโโโโโโโ
2:13:03
โโโโโโโโโโโโโโโโโโโโโโ
BB – “Why did it take so long for it, for it to come out”
======================================
DJT – Sure, but thatโs not gonna, you know like, answer an overall question of, you know, somebody did a comparative study of all clinical trials, and, when they were finished, and at, and when the study was actually published afterwards
You know, thatโs only gonna be one, particular clinical study
======================================
BB – “Right”
“Um, but it it would, perhaps, answer the question; because youโre using it as an example on the basis of which to dismiss criticism, whether or not, uh, it is the standard, and therefor youโre allowed to accept that Burzynski hasnโt published until 2016, or, um, itโs an anomaly, which is also a possibility, that most stuff comes out more quickly“
======================================
DJT – Well, we know that the Declaration of Helsinki doesnโt even give a standard saying, โYou must publish within x amount of years,โ you know ?
So, Iโve yet to find a Skeptic who posted something that said, โHere are the standards, published hereโ
======================================
2:14:07
โโโโโโโโโโโโโโโโโโโโโโ
BB – “I I, yeah, the other thing that David James points out is you know, why 2016 when heโs had 36 years already ?“
======================================
DJT – Again, we get back to, when the clinical trial is finished, not when Burzynski started
======================================
BB – “Treating people”
======================================
DJT – I mean, you would expect to find a results to be published after, the final results are in
======================================
BB – “You would expect the Burzynski Patient Group to be a lot bigger after 36 years, and in fact is
======================================
DJT – You would expect some people would want to have confidentiality, and maybe not want to be included
======================================
BB – “So, if youโre unsure about this stuff, if youโre unsure about the the time to publication, why are you defending it so hard, other than saying, โI donโt know, I really need toโ
======================================
DJT – Why am I unsure ?
======================================
BB – “Uh about the
======================================
DJT – (laughing) I just gave you an example
======================================
BB – “The reasons, the reasons for which that heโs, no, why are you defending him so hard, when youโre unsure ?
โโโโโโโโโโโโโโโโโโโโโโ
2:15:02
======================================
DJT – Oh, who said I was unsure ?
I just gave you an example
โโโโโโโโโโโโโโโโโโโโโโ
Note how Bob ASSUMES that I’m “unsure” when I had the same answer since 0:32:07 [12]
Bob, who approves “Accelerated Approval” ?
1. FDA ?
2. A peer-reviewed scientific journal ?
3. The Skepticsโข ?
Bob, It’s your unlucky [13]
======================================
REFERENCES:
======================================
[1] – September 28, 2013 โThe Skepticsโขโ Burzynski discussion: By Bob Blaskiewicz โ 2:19:51
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/10/04/september-28-2013-the-skeptics-burzynski-discussion-by-bob-blaskiewicz-21951/
======================================
[2] – FDA grants Orphan Drug Designation (ODD) for A10 and AS2-1:
โโโโโโโโโโโโโโโโโโโโโโ
Click to access PressRelease_12022008_BZYR(2).pdf
โโโโโโโโโโโโโโโโโโโโโโ
josephinejones (@_JosephineJones), D Nile ist http://josephinejones.wordpress.com/2013/01/23/happy-birthday-dr-burzynski-and-goodbye-antineoplastons/comment-page-1/#comment-8921
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/09/23/josephinejones-_josephinejones-d-nile-ist-httpjosephinejones-wordpress-com20130123happy-birthday-dr-burzynski-and-goodbye-antineoplastonscomment-page-1comment-8921/
======================================
[3] – The Skeptics @Majikthyse reveals madjik research skilz:
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/09/26/the-skeptics-majikthyse-reveals-madjik-research-skilz/
======================================
[4] – Critiquing David H. Gorski, MD, PhD, FACS http://www.sciencebasedmedicine.org/editorial-staff/david-h-gorski-md-phd-managing-editor/
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/08/21/critiquing-david-h-gorski-md-phd-facs-www-sciencebasedmedicine-orgeditorial-staffdavid-h-gorski-md-phd-managing-editor/
======================================
[5] – The Lancet Oncology
โโโโโโโโโโโโโโโโโโโโโโ
http://www.thelancet.com/journals/lanonc/onlinefirst
โโโโโโโโโโโโโโโโโโโโโโ
http://www.thelancet.com/journals/lanonc/issue/current
======================================
[6] – FINALLY, one of โThe Skepticsโขโ has the โBallsโ to do what even Dr. David H. โOracโ Gorski would NOT do:
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/09/12/finally-one-of-the-skeptics-has-the-balls-to-do-what-even-dr-david-h-orac-gorski-would-not-do/
======================================
[7] – Burzynski โ The Antineoplaston Randomized Japan Phase II Clinical Trial Study:
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/03/28/burzynski-the-antineoplaston-randomized-japan-phase-ii-clinical-trial-study/
======================================
[8] – Critiquing: National Cancer Institute (NCI) at the National Institutes of Health (NIH) CancerNet โfact sheetโ:
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/09/19/critiquing-national-cancer-institute-nci-at-the-national-institutes-of-health-nih-cancernet/
======================================
[9] – Stanislaw Rajmund Burzynski Publications:
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/03/16/stanislaw-rajmund-burzynski-publications/
======================================
[10] – Critiquing: In which the latest movie about Stanislaw Burzynski โcancer cureโ is reviewedโฆwith Insolence:
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/07/18/critiquing-in-which-the-latest-movie-about-stanislaw-burzynski-cancer-cure-is-reviewed-with-insolence-2/
======================================
[11] – QUESTIONS the Critics and Cynics, โThe Skepticsโขโ do NOT want to ANSWER:
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/06/23/questions-the-critics-and-cynics-the-skeptics-do-not-want-to-answer/
======================================
[12] – The Biggest Loser: โThe Skepticsโขโ Guy Chapman (guychapman @vGuyUK @SceptiGuy) http://www.chapmancentral.co.uk/blahg/ โ September 28, 2013 โThe Skepticsโขโ Burzynski discussion: By Bob Blaskiewicz โ 2:19:51
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/10/18/the-biggest-loser-the-skeptics-guy-chapman-guychapman-vguyuk-sceptiguy-httpwww-chapmancentral-co-ukblahg-september-28-2013-the-skeptics/
======================================
[13] – Burzynski: Why has the FDA NOT granted Accelerated Approval for Antineoplastons A10 (Atengenal) and AS2-1 (Astugenal) ?:
โโโโโโโโโโโโโโโโโโโโโโ
https://stanislawrajmundburzynski.wordpress.com/2013/07/28/burzynski-why-has-the-fda-not-granted-accelerated-approval-for-antineoplastons-a10-astengenal-and-as2-1-astugenal/
======================================